Antonia Estela Perez – Trademark Portfolio

Entity Type: 01

Antonia Estela Perez holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HERBAN CURA. The owner is based in West New York, NY.

159-34 Riverside Drive, Aot 2A-90

West New York, NY 10032

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Antonia Estela Perez's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Antonia Estela Perez have?

Antonia Estela Perez has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Antonia Estela Perez file in?

Antonia Estela Perez files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Antonia Estela Perez's most well-known trademarks?

Antonia Estela Perez's registered trademark portfolio includes well-known marks such as HERBAN CURA. These are among 1 currently registered trademark in the portfolio.

What is Antonia Estela Perez's trademark registration success rate?

Antonia Estela Perez has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.